Pulmonary infiltrates and hypoxemia in patients with the acquired immunodeficiency syndrome re-exposed to trimethoprim-sulfamethoxazole

Am Rev Respir Dis. 1987 Oct;136(4):1003-4. doi: 10.1164/ajrccm/136.4.1003.

Abstract

Fever, hypotension, pulmonary infiltrates, and hypoxemia developed upon re-exposure to trimethoprim-sulfamethoxazole in 2 patients with the Acquired Immunodeficiency Syndrome. This reaction can mimic sepsis or the clinical worsening of underlying pulmonary opportunistic infection. The literature concerning adverse pulmonary effects of trimethoprim-sulfamethoxazole is reviewed.

Publication types

  • Case Reports

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Adult
  • Drug Combinations / adverse effects
  • Exudates and Transudates / drug effects*
  • Humans
  • Hypoxia / chemically induced*
  • Lung / drug effects*
  • Male
  • Middle Aged
  • Opportunistic Infections / complications
  • Opportunistic Infections / drug therapy
  • Pneumonia, Pneumocystis / complications
  • Pneumonia, Pneumocystis / drug therapy
  • Sulfamethizole / adverse effects*
  • Sulfathiazoles / adverse effects*
  • Trimethoprim / adverse effects*

Substances

  • Drug Combinations
  • Sulfathiazoles
  • Sulfamethizole
  • trimethoprim sulfamethizole
  • Trimethoprim